Ethyl 3-(pyridin-2-ylamino)propanoate,
103041-38-9,
N-[2]pyridyl-B-alanin-ethyl ester,
Ethyl 3-(2-Pyridylamino)propanoate,
Ethyl3-(pyridin-2-ylamino)propanoate,
N-2-Pyridinyl-beta-alanine ethyl ester,
ethyl 3-(2-pyridylamino)propionate,
AK-31676,
A1-00095,
Ethyl 3-((pyridin-2-yl)amino)propanoate,
ethyl 3-[(pyridin-2-yl)amino]propanoate,
ACMC-20aqkc,
PubChem18107,
3-(pyridin-2-ylamino)propionic acid ethyl ester,
3-(Pyridin-2-ylaMino)-propionic acid ethyl ester,
ALA001,
SCHEMBL1602631,
CTK0H2463,
DTXSID90475203,
UITNIDFEANEWPC-UHFFFAOYSA-N,
BCP08905,
CS-M2454,
AN-495,
MFCD09833621,
SC3891,
ZINC22011551,
AKOS005266613,
AC-7902,
DS-0761,
QC-6151,
RP25320,
TRA0006707,
N-(2-Pyridyl)-beta-alanine ethyl ester,
BC224361,
BR-31676,
C120,
N-Ethyl 3-(pyridin-2-ylaMino)propanoate,
SY021323,
AB0000720,
AX8142481,
DB-004038,
ST2412955,
TC-067596,
BB 0253984,
E1214,
FT-0650193,
X8641,
3-(2-Pyridylamino)propionic Acid Ethyl Ester,
B-1865,
3-(pyridyl-2-amino) propionic acid ethyl ester,
MFCD09833621 (97+%),
041E389,
I14-5126,
J-520819,
3-(p-Tolyl)propionic acid,
C10H14N2O2,
ACN-028611,
CB11790,
CID11984503,
|A-Alanine, N-2-pyridinyl-, ethyl ester,
A1845,
EC 600-382-4,
Dabigatran intermediate;Alanine, N-2-pyridinyl-, ethyl ester,